Annual report pursuant to Section 13 and 15(d)

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)

v3.10.0.1
Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Income Tax Disclosure [Abstract]      
Net operating loss and capital loss carryforward $ 3,595 $ 18,019 $ 16,921
Consulting-royalty costs (8)
Trademark 21 576 671
Investment in Phusion 33 938 1,103
Depreciation 41 (304) (103)
Other 604 1,159 802
Valuation allowance (4,294) (20,388) (19,386)
Total